Skip to main content

Quadratus lumborum versus transversus abdominis plane block for postoperative analgesia in laparoscopic colorectal surgery: a systematic review and meta-analysis of randomized controlled trials

In brief

Quadratus lumborum blocks cut 24-hour opioid use by about 9 mg

Across four randomized trials involving 419 patients, quadratus lumborum blocks reduced opioid use by about 9 mg of morphine equivalents in the first 24 hours compared with transversus abdominis plane blocks, with slightly lower pain scores at rest and during movement. Nausea and dizziness rates did not differ significantly; moderate evidence and substantial variability leave larger trials needed before routine preference.

Journal
Techniques in coloproctology (Q1)
Published
15 November 2026
Study design
Systematic review / meta-analysis of RCTs
Evidence level
Level 1, High (CEBM 1a)
Authors
I Moqbel, M N Elshabrawi, M M Tawadros, A I Abdelmeguid, F T Shereer, A Ei Hilali, et al.
PMID
43035539
DOI
10.1007/s10151-026-03405-6

Why clinicians should know about it

Abstract

BACKGROUND: Effective pain management after surgery is crucial for recovery following laparoscopic colorectal resection in enhanced recovery after surgery (ERAS) programs. While the transversus abdominis plane (TAP) block is commonly used, it may not fully address visceral pain. The quadratus lumborum (QL) block might provide better coverage for both somatic and visceral pain due to its ability to spread to the thoracolumbar fascia and paravertebral space. OBJECTIVES: This study aims to compare the clinical outcomes of QL versus TAP blocks in laparoscopic colorectal surgery. The main outcome was total opioid use within 24 h. Secondary outcomes included early pain scores, time until the first rescue analgesic was needed, postoperative nausea and vomiting (PONV), length of stay, surgical complications, and side effects related to the blocks. METHODS: We conducted a systematic literature search using PubMed, Cochrane CENTRAL, Web of Science Core Collection, and Scopus from database inception to 27 July 2025 for randomized controlled trials (RCTs) comparing QL and TAP blocks. Two reviewers independently screened the studies, extracted data, and assessed quality using the Cochrane Risk of Bias 2 tool. We calculated pooled estimates using a random-effects model and evaluated the reliability of the evidence on the basis of the grading of recommendations, assessment, development, and evaluation (GRADE) framework. RESULTS: Four RCTs (n = 419) met the inclusion criteria. Compared with the TAP block, the QL block led to lower opioid use within 24 h (MD [mean difference] -8.92 mg morphine equivalents; 95% CI -11.57 to -6.28) and reduced pain scores both at rest MD -0.25 (-0.37 to -0.21) and during movement MD -0.40 [-0.52 to -0.29]. Operative time numerically favored the QL block, but the pooled difference was not statistically significant. The rates of PONV (OR 0.54; 95% CI 0.25-1.19) and dizziness (OR 0.60; 95% CI 0.22-1.63) were not significantly different between the two groups. The evidence was rated high for PONV and operative time, and moderate for opioid consumption, pain at rest, pain during movement, and dizziness, reflecting downgrades for imprecision and, for opioid consumption and pain during movement, substantial-to-high heterogeneity (I2 85% and 93%, respectively). CONCLUSIONS: In laparoscopic colorectal surgery, the QL block shows better opioid-sparing effects and lower pain scores at rest and during movement than the TAP block. Operative time numerically favored the QL block but did not differ significantly between groups. Importantly, it does not lead to more adverse effects. These findings suggest that the QL block may be a useful opioid-sparing option within ERAS-based perioperative care, although larger multicenter RCTs are needed before routine preference over the TAP block can be firmly recommended.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.